Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Clinicopathologic features and surgical management of primary umbilical melanoma: a case series.

Di Monta G, Caracò C, Marone U, Grimaldi AM, Anniciello AM, Di Marzo M, Simeone E, Mori S.

BMC Res Notes. 2015 Apr 15;8:147. doi: 10.1186/s13104-015-1096-x.

2.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Mar 11. pii: S0748-7983(15)00078-5. doi: 10.1016/j.ejso.2015.02.005. [Epub ahead of print]

PMID:
25800935
3.

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.

Manca A, Lissia A, Capone M, Ascierto PA, Botti G, Caracò C, Stanganelli I, Colombino M, Sini M, Cossu A, Palmieri G.

J Transl Med. 2015 Jan 28;13:37. doi: 10.1186/s12967-015-0401-8.

4.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report.

Grimaldi AM, Simeone E, Palla M, Festino L, Caracò C, Mozzillo N, Petrillo A, Muto P, Ascierto PA.

Anticancer Drugs. 2015 Apr;26(4):464-8. doi: 10.1097/CAD.0000000000000206.

PMID:
25622086
5.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Terranova Barberio M, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A.

BMC Cancer. 2014 Nov 24;14:875. doi: 10.1186/1471-2407-14-875.

6.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2014 May 14;3:e28780. eCollection 2014.

7.

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Macripò G, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

JAMA Surg. 2014 Jul;149(7):700-6. doi: 10.1001/jamasurg.2013.5676.

PMID:
24804856
8.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.

Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA.

Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3. Erratum in: Cancer Immunol Immunother. 2014 Nov;63(11):1233.

PMID:
24695951
9.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M, Rossi CR.

J Clin Oncol. 2014 Mar 20;32(9):935-41. doi: 10.1200/JCO.2013.50.7681. Epub 2014 Feb 10.

10.

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.

Aloj L, D'Ambrosio L, Aurilio M, Morisco A, Frigeri F, Caraco' C, Di Gennaro F, Capobianco G, Giovannoni L, Menssen HD, Neri D, Pinto A, Lastoria S.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):867-77. doi: 10.1007/s00259-013-2658-6. Epub 2014 Jan 17.

PMID:
24435772
11.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

Ann Oncol. 2014 Jan;25(1):240-6. doi: 10.1093/annonc/mdt510.

12.

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.

Caracò C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, Di Cecilia ML, Botti G, Ascierto PA.

BMC Cancer. 2013 Dec 1;13:564. doi: 10.1186/1471-2407-13-564.

13.

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F.

J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17.

14.

Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma.

Caracò C, Marone U, Di Monta G, Aloj L, Caracò C, Anniciello A, Lastoria S, Botti G, Mozzillo N.

Ann Surg Oncol. 2014 Jan;21(1):300-5. doi: 10.1245/s10434-013-3285-y. Epub 2013 Oct 1.

PMID:
24081802
15.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N.

Eur J Surg Oncol. 2014 Jan;40(1):61-6. doi: 10.1016/j.ejso.2013.09.002. Epub 2013 Sep 12.

PMID:
24075826
16.

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.

Colombino M, Lissia A, Capone M, De Giorgi V, Massi D, Stanganelli I, Fonsatti E, Maio M, Botti G, Caracò C, Mozzillo N, Ascierto PA, Cossu A, Palmieri G.

J Transl Med. 2013 Aug 29;11:202. doi: 10.1186/1479-5876-11-202.

17.

Sentinel node biopsy in thin and thick melanoma.

Mozzillo N, Pennacchioli E, Gandini S, Caracò C, Crispo A, Botti G, Lastoria S, Barberis M, Verrecchia F, Testori A.

Ann Surg Oncol. 2013 Aug;20(8):2780-6. doi: 10.1245/s10434-012-2826-0. Epub 2013 May 30.

PMID:
23720068
18.

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

Nasti G, Piccirillo MC, Izzo F, Ottaiano A, Albino V, Delrio P, Romano C, Giordano P, Lastoria S, Caracò C, de Lutio di Castelguidone E, Palaia R, Daniele G, Aloj L, Romano G, Iaffaioli RV.

Br J Cancer. 2013 Apr 30;108(8):1566-70. doi: 10.1038/bjc.2013.140. Epub 2013 Apr 4.

19.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.

Daponte A, Signoriello S, Maiorino L, Massidda B, Simeone E, Grimaldi AM, Caracò C, Palmieri G, Cossu A, Botti G, Petrillo A, Lastoria S, Cavalcanti E, Aprea P, Mozzillo N, Gallo C, Comella G, Ascierto PA; Southern Italy Cooperative Oncology Group (SICOG).

J Transl Med. 2013 Feb 13;11:38. doi: 10.1186/1479-5876-11-38.

20.

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.

Mozzillo N, Caracò C, Marone U, Di Monta G, Crispo A, Botti G, Montella M, Ascierto PA.

World J Surg Oncol. 2013 Feb 4;11:36. doi: 10.1186/1477-7819-11-36.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk